Group 1 - The core viewpoint of the news is that 威士顿's stock has shown significant fluctuations in price and trading volume, with a notable increase in the past few days despite a decrease over the past 20 days [1] - As of January 8, 威士顿's stock price increased by 2.06% to 61.84 CNY per share, with a total market capitalization of 5.442 billion CNY [1] - The company has a diverse revenue structure, with software development accounting for 43.04%, operation and maintenance services 24.89%, software product sales and services 19.63%, system integration 10.75%, and other services 1.69% [1] Group 2 - 威士顿 operates in the computer software development sector, specifically in horizontal general software, and is involved in concepts such as digital twins, digital economy, AI agents, ERP concepts, and artificial intelligence [2] - As of November 30, 威士顿 had 18,000 shareholders, a decrease of 4.37% from the previous period, with an average of 2,054 circulating shares per shareholder, an increase of 4.56% [2] - For the period from January to September 2025, 威士顿 reported a revenue of 122 million CNY, a year-on-year decrease of 32.34%, and a net profit attributable to shareholders of 21.49 million CNY, down 28.30% year-on-year [2] Group 3 - 威士顿 has distributed a total of 66 million CNY in dividends since its A-share listing [3]

（文章来源：每日经济新闻） 威士顿（301315.SZ）1月7日在投资者互动平台表示，公司研发的"威士顿工业AI智能体软件"已经获得 软件产品证书，并已运用于实际科创项目当中。同时，公司是首批入选2025年上海市"AI+制造"专业服 务商目录的制造业智能体和应用服务商。 每经AI快讯，有投资者在投资者互动平台提问：智能体是一种能够感知环境、进行决策并采取行动的 智能系统，旨在达成特定目标。与传统的大型语言模型（LLM）相比，AI Agent不仅具备理解和生成文 本的能力，还能够主动规划、实施行动并与环境进行交互。 威士顿可以吗？ ...

Group 1 - The core viewpoint of the news is that 威士顿 (Winston) has shown fluctuations in its stock performance and financial metrics, indicating both growth and challenges in its business operations [1][2]. Group 2 - As of January 6, 威士顿's stock price increased by 2.10% to 59.45 CNY per share, with a total market capitalization of 5.232 billion CNY [1]. - The company experienced a net inflow of main funds amounting to 2.4766 million CNY, with significant buying activity from large orders [1]. - Year-to-date, 威士顿's stock has risen by 3.97%, but it has seen a decline of 10.33% over the past 20 days [1]. Group 3 - 威士顿's main business segments include software development (43.04%), operation and maintenance services (24.89%), software product sales and services (19.63%), system integration (10.75%), and others (1.69%) [1]. - The company operates in the fields of intelligent manufacturing and digital finance, and is categorized under the computer-software development industry [1]. Group 4 - As of November 30, 威士顿 had 18,000 shareholders, a decrease of 4.37% from the previous period, while the average circulating shares per person increased by 4.56% [2]. - For the period from January to September 2025, 威士顿 reported a revenue of 122 million CNY, a year-on-year decrease of 32.34%, and a net profit of 21.4859 million CNY, down 28.30% year-on-year [2]. Group 5 - 威士顿 has distributed a total of 66 million CNY in dividends since its A-share listing [3].

证券日报网讯12月31日，威士顿（301315）在互动平台回答投资者提问时表示，截至2025年11月30日公 司股东人数是18009户。为保证所有投资者平等获悉公司信息，公司在定期报告中披露对应时点的股东 信息。 ...

一、 培训主要内容 兴业证券股份有限公司 关于上海威士顿信息技术股份有限公司 2025 年持续督导培训情况报告书 为了进一步提高上海威士顿信息技术股份有限公司（以下简称"威士顿"或 "公司"）上市后规范运作水平，促进公司的健康发展，兴业证券股份有限公司（以 下简称"兴业证券"或"我公司"）特对威士顿进行了相关培训。现将培训情况汇报 如下： | 培训时间 | 年 | 月 | 日 | 2025 | 12 | 23 | | --- | --- | --- | --- | --- | --- | --- | | 培训地点 | 上海市长宁区中山万博 | 楼威士顿会议室 | 16 | | | | | 培训主题 | 年上市公司监管规则修订、问询及处罚动态 | 2025 | | | | | | 培训讲师 | 朱译、张衡、茅宇润 | | | | | | | 参训人员 | 公司董事、高级管理人员、中层以上管理人员及实际控制人等 | | | | | | 保荐代表人（签字）： 朱 译 保荐代表人（签字）： 张 衡 兴业证券股份有限公司 年 月 日 本次培训的主题为 2025 年上市公司监管规则修订、问询及处罚动态，结合 《公司法》《 ...

Group 1 - The company announced that it will hold a staff representative meeting on December 24, 2025, to elect Mr. Zhang Wei as the employee representative director of the fourth board of directors, with a term lasting until the end of the fourth board's term [2] - Mr. Zhang Wei was previously a non-employee representative director and deputy general manager of the fourth board of directors, and will retain his position as deputy general manager after this election [2]

上述职工代表董事符合《公司法》《公司章程》等相关法律法规和制度规定 的关于职工代表董事任职的资格和条件。本次选举完成后，公司第四届董事会人 员及各专门委员会成员构成不变，董事会中兼任高级管理人员职务的董事以及由 职工代表担任的董事人数总计未超过公司董事总数的二分之一。 特此公告。 上海威士顿信息技术股份有限公司 证券代码：301315 证券简称：威士顿 公告编号：2025-054 上海威士顿信息技术股份有限公司 关于选举职工代表董事的公告 本公司及董事会全体成员保证信息披露内容真实、准确和完整，没有虚假记 载、误导性陈述或重大遗漏。 根据《中华人民共和国公司法》（以下简称"《公司法》"）《上海威士顿 信息技术股份有限公司章程》（以下简称"《公司章程》"）等有关规定，上海 威士顿信息技术股份有限公司（以下简称"公司"）于 2025 年 12 月 24 日召开 职工代表大会，选举张伟先生（简历详见附件）为公司第四届董事会职工代表董 事，任期至公司第四届董事会届满之日止。 张伟先生原为公司第四届董事会非职工代表董事、副总经理，本次选举完成 后，其变更为公司第四届董事会职工代表董事，副总经理职务不变。 董事会 202 ...

Group 1 - A-shares and Hong Kong stocks experienced a significant rebound, with the Shanghai Composite Index rising by 1.19% and the Hang Seng Index increasing by 0.92% [1] - The largest medical ETF in the market (512170) and the only drug ETF (562050) both rose over 1%, indicating a broad recovery in the medical sector [1] - The medical ETF (512170) showed a strong technical signal with a "bullish engulfing" pattern, suggesting a potential trend reversal [1] Group 2 - The pharmaceutical sector in A-shares also saw a surge, with the drug ETF (562050) rising by 1.19%, driven by contributions from innovative and traditional Chinese medicine stocks [3] - The drug ETF (562050) has approximately 25% weight in traditional Chinese medicine, which helps mitigate the volatility of the overall pharmaceutical index [3] Group 3 - The Hong Kong innovation drug sector is showing signs of recovery, with the Hong Kong innovation drug ETF (520880) successfully closing in the green, attracting "bottom-fishing" funds [5] - The fund size of the Hong Kong innovation drug ETF (520880) reached a new high of 4.172 billion shares, reflecting strong investor interest [5] Group 4 - The A+H pharmaceutical sector has been in a correction phase for three months, and analysts suggest that this may be an opportune time for medium to long-term investments in pharmaceutical assets [8] - Recent positive developments in the pharmaceutical industry include overseas collaborations and increasing demand for CXO services, indicating a favorable outlook for the sector [9] Group 5 - The fund manager of the Hong Kong innovation drug ETF (520880) maintains a balanced allocation strategy, highlighting the potential for recovery in the innovative drug industry and related sectors [10] - New investment tools, such as the Hong Kong medical ETF (159137), are being launched to track the medical innovation theme, covering various core leaders in the medical field [7]

Market Overview - As of December 5, the Shanghai Composite Index closed at 3902.81 points, up 27.01 points, with a gain of 0.70% [1] - The Shenzhen Component Index closed at 13147.68 points, up 140.96 points, with a gain of 1.08% [1] - The ChiNext Index closed at 3109.30 points, up 41.81 points, with a gain of 1.36% [1] Stock Performance - A total of 82 A-shares had a turnover rate exceeding 20% on this day, with N-Moore-U reaching a turnover rate of over 50% [1] - N-Moore-U (688795) had a closing price of 600.50 CNY, with a turnover rate of 85.49% and a remarkable increase of 425.46% [1] - Other notable stocks with high turnover rates include: - Chuling Information (300250) with a turnover rate of 46.01% and a decline of 7.22% [1] - Sichuan Jinding (600678) with a turnover rate of 44.89% and a slight decline of 0.74% [1] - C China Uranium (001280) with a turnover rate of 44.11% and a decrease of 5.18% [1] - Jinfu Technology (003018) with a turnover rate of 43.71% and a marginal increase of 0.10% [1] Additional Notable Stocks - Weston (301315) closed at 66.30 CNY with a turnover rate of 43.08% and an increase of 5.20% [1] - Haixin Food (002702) closed at 9.55 CNY with a turnover rate of 42.20% and a gain of 10.02% [1] - Tongyu Communication (002792) closed at 29.47 CNY with a turnover rate of 41.60% and an increase of 4.73% [1] - Other stocks with significant turnover rates include: - Huawu Co., Ltd. (300095) with a turnover rate of 39.34% and a decline of 2.40% [1] - Zhongneng Electric (300062) with a turnover rate of 38.89% and an increase of 12.76% [1] - Xiaocheng Technology (300139) with a turnover rate of 38.76% and a gain of 14.62% [1]

Group 1 - The stock of Weston increased by 5.20% with a turnover rate of 43.08%, and a total transaction amount of 1.049 billion yuan, showing a volatility of 13.04% [2] - Institutional investors net sold 41.61 million yuan, while the total net selling by brokerage seats amounted to 15.44 million yuan [2] - The stock was listed on the daily trading list due to its turnover rate reaching 43.08%, with the top five brokerage seats contributing to a total transaction of 226 million yuan, where the buying amount was 84.25 million yuan and the selling amount was 141 million yuan, resulting in a net selling of 57.06 million yuan [2] Group 2 - Over the past six months, the stock has appeared on the trading list five times, with an average price drop of 1.26% the day after being listed and an average drop of 2.04% over the following five days [3] - The stock experienced a net outflow of 12.98 million yuan in principal funds today, with a significant outflow of 10.28 million yuan from large orders and 2.70 million yuan from major orders [3] - In the last five days, the stock saw a net inflow of 14.97 million yuan in principal funds [3] Group 3 - Detailed trading information on December 5 shows that institutional seats were involved in both buying and selling, with the largest buy amounting to 25.74 million yuan and the largest sell amounting to 39.83 million yuan [4] - The top four buying seats were all institutional, with total buying amounts of 25.74 million yuan, 16.60 million yuan, 15.79 million yuan, and 14.99 million yuan, while the selling amounts were 39.83 million yuan, 31.41 million yuan, 39.83 million yuan, and 22.74 million yuan respectively [4]